Effects of MAPK and PI3K Pathways on PD-L1 Expression in Melanoma
Abstract Purpose: PD-L1 is the main ligand for the immune inhibitory receptor PD-1. This ligand is frequently expressed by melanoma cells. In this study, we investigated whether...
Publications
2 shownMelanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Activating B-RAF(V600E) (also known as BRAF) kinase mutations occur in ∼7% of human malignancies and ∼60% of melanomas. Early clinical experience with a novel clas...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 2,455
- Institution
- University of California, Los Angeles
External Links
Identifiers
- ORCID
- 0009-0000-2307-6209
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.